[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100635915":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":22,"responsibleParty":38,"collaborators":10,"id":40,"slug":10,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":45,"eligibilityCriteria":46,"healthyVolunteers":41,"sex":47,"minAge":48,"maxAge":10,"enrollmentInfo":49,"targetDuration":52,"studyType":53,"phases":10,"briefSummary":54,"conditions":55,"keywords":58,"overallStatus":25,"whyStopped":10,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Endometrial cancer patients",null,"All patients undergoing staging and cytoreduction surgery for endometrial cancer",[13],{"name":14,"affiliation":5,"role":15},"Francesco Fanfani","PRINCIPAL_INVESTIGATOR",[17],{"name":18,"role":19,"phone":20,"phoneExt":10,"email":21},"Francesco Fanfani, MD","CONTACT","+390630133421","francesco.fanfani@policlinicogemelli.it",[23],{"facility":24,"status":25,"city":26,"state":10,"zip":27,"country":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"Fondazione Policlinico Universitario Agostino Gemelli, IRCCS","RECRUITING","Roma","00136","Italy",{"type":30,"coordinates":31},"Point",[32,33],11.10642,44.99364,{"lat":33,"lon":32},[36],{"name":18,"role":19,"phone":37,"phoneExt":10,"email":21},"0630153421",{"type":39,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100635915",false,"NCT07558889","The Surveillance, Epidemiology, and End Results Database Program on Endometrial Cancer in the Italian Population","The ENDOCancer-DATA: the Surveillance, Epidemiology, and End Results Database Program on Endometrial Cancer in the Italian Population","ENDOCancerDATA","Inclusion Criteria:\n\n* diagnosis of endometrial cancer (stage I-IV, G1-3, and special histotypes)\n* age \\> 18 years\n* American Society of Anesthesiologists classification (ASA score) 1-3\n* patients undergoing staging, cytoreduction or diagnostic surgery with acquisition of histological examination on which IHC and\u002For NGS studies have been performed for the molecular profile of the carcinoma\n* Signed informed consent\n\nExclusion Criteria:\n\n* patients with missing information\n* patients not treated in the participating centers for which only partial and fragmented information will be available\n* molecular profile not known and\\\\or not recoverable and retrospectively analysable","FEMALE","18 Years",{"count":50,"type":51},10000,"ESTIMATED","10 Years","OBSERVATIONAL","The aim of this study is to lay the bases for an ambitious project that reports and records all the epidemiological-clinical information of the cases of endometrial carcinoma diagnosed and treated in the reference oncology centers involved on the national territory, to create a process of analysis of the data",[56,57],"Endometrium Cancer","Gynecologic Cancer",[59,60,61,62,63,64],"Molecular classification","Endometrial cancer treatment","Endometrial cancer epidemiology","Endometrial cancer surgical procedures","Minimally invasive surgery","Gynecologic Oncology","2026-04-27",{"date":67,"type":68},"2026-04-30","ACTUAL",{"date":70,"type":68},"2024-04-01",{"date":72,"type":51},"2034-01-01",{"name":5,"class":6},1]